Biotech Values

[DewDiligence]

I agree and previously posted that, even if SPPI manages to obtain regulatory approval, another non-substitutable Rituxan knockoff in the US market is apt to be a commercial bust. I highly doubt that SPPI and its partner have the technological prowess to get the FDA to designate their Rituxan knockoff as substitutable for the branded product.